Nixon Peabody Trust’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,006
Closed -$270K 162
2025
Q4
$270K Sell
1,006
-27
-3% -$6.86K 0.02% 137
2025
Q3
$255K Sell
1,033
-526
-34% -$137K 0.02% 139
2025
Q2
$466K Buy
1,559
+325
+26% +$99K 0.04% 114
2025
Q1
$385K Sell
1,234
-148
-11% -$52.3K 0.03% 125
2024
Q4
$486K Buy
1,382
+52
+4% +$18.7K 0.04% 103
2024
Q3
$470K Hold
1,330
0.04% 102
2024
Q2
$404K Sell
1,330
-61
-4% -$18.7K 0.04% 102
2024
Q1
$482K Buy
1,391
+651
+88% +$237K 0.04% 91
2023
Q4
$260K Buy
+740
New +$239K 0.03% 113

Other funds holding ACN

Nixon Peabody Trust's ACN Position: Q1 2026 in Review

Nixon Peabody Trust sold out of Accenture (ACN) in Q1 2026, closing a stake of 1,006 shares — an estimated $270K sold.

Nixon Peabody Trust first reported a position in ACN in Q4 2023 and held it in 9 quarters. The position peaked at $486K in Q4 2024. 2,150 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • Nixon Peabody Trust reported no remaining Accenture position as of Q1 2026 after selling out during the quarter.
  • Nixon Peabody Trust sold 1,006 Accenture shares in Q1 2026, an estimated $270K.
  • Nixon Peabody Trust first reported a position in Accenture in Q4 2023 and held it in 9 quarters.
  • Nixon Peabody Trust's Accenture position peaked at $486K in Q4 2024.
  • 2,150 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Nixon Peabody Trust's 13F filing for Q1 2026, filed 27 Apr 2026.